Clinical Trial Update: Excretion of Rivaroxaban in Human Breast Milk [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating excretion of rivaroxaban into human breast milk in postpartum women; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Postpartum, VTE Prophylaxis | Phase 1 | Status: RECRUITING